MetLife Investment Advisors »

Edgewise Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $256k 23k 10.94
2023-09-30 $134k 23k 5.73
2023-06-30 $181k 23k 7.75
2023-03-31 $156k 23k 6.67
2022-12-31 $209k 23k 8.94
2022-09-30 $230k 23k 9.85
2022-06-30 $186k 23k 7.96
2022-03-31 $227k 23k 9.70
2021-12-31 $230k 15k 15.31